CSIMarket
 


Jazz Pharmaceuticals Plc  (JAZZ)
Other Ticker:  
 
 

JAZZ's Net Income Growth by Quarter and Year

Jazz Pharmaceuticals Plc's Net Income results by quarter and year




JAZZ Net Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 94.15 -341.35 -210.76 85.20
III Quarter September 146.82 -19.65 73.99 159.47
II Quarter June 104.44 34.67 102.28 149.32
I Quarter March 69.42 -779.04 261.90 92.32
FY   414.83 -1,105.37 227.41 486.31



JAZZ Net Income fourth quarter 2023 Y/Y Growth Comment
Jazz Pharmaceuticals Plc in the fourth quarter 2023 achieved Net Income of $ 94.15 millions compare to net loss recorded in same quarter a year ago.

Looking into fourth quarter 2023 results within Major Pharmaceutical Preparations industry 13 other companies have achieved higher Net Income growth. While Jazz Pharmaceuticals Plc' s Net Income no change of % ranks overall at the positon no. 974 in the fourth quarter 2023.




JAZZ Net Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - 85.26 %
III Quarter September - - -53.6 % -31.33 %
II Quarter June 201.24 % -66.1 % -31.5 % 135.04 %
I Quarter March - - 183.69 % -12.58 %
FY   - - -53.24 % 8.71 %

Financial Statements
Jazz Pharmaceuticals Plc's fourth quarter 2023 Net Income $ 94.15 millions JAZZ's Income Statement
Jazz Pharmaceuticals Plc's fourth quarter 2022 Net Income $ -341.35 millions Quarterly JAZZ's Income Statement
New: More JAZZ's historic Net Income Growth >>


JAZZ Net Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December -35.87 % - - -46.57 %
III Quarter September 40.58 % - -27.66 % 6.8 %
II Quarter June 50.45 % - -60.95 % 61.74 %
I Quarter March - - 207.39 % 100.74 %
FY (Year on Year)   - - -53.24 % 8.71 %




Net Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #14
Healthcare Sector #74
Overall #974

Net Income Y/Y Growth Statistics
High Average Low
503.91 % 42.85 % -80.19 %
(Dec 31 2012)   (Mar 31 2018)
Net Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #14
Healthcare Sector #74
Overall #974
Net Income Y/Y Growth Statistics
High Average Low
503.91 % 42.85 % -80.19 %
(Dec 31 2012)   (Mar 31 2018)

Net Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Jazz Pharmaceuticals Plc's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
503.91 % 42.85 % -80.19 %
(Dec 31 2012)  


JAZZ's IV. Quarter Q/Q Net Income Comment
In the IV. Quarter 2023 Jazz Pharmaceuticals Plc reported fall in Net Income sequentially by -35.87% to $ 94.15 millions, from $ 146.82 millions declared in the previous reporting period.

Within Major Pharmaceutical Preparations industry 13 other companies have achieved higher Net Income quarter on quarter growth. While Jazz Pharmaceuticals Plc's Net Income growth quarter on quarter, overall rank is 974.


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #14
Healthcare Sector #74
Overall #974
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #14
Healthcare Sector #74
Overall #974
Net Income Q/Q Growth Statistics
High Average Low
503.91 % 42.85 % -80.19 %
(Dec 31 2012)  


JAZZ's IV. Quarter Q/Q Net Income Comment
In the IV. Quarter 2023 Jazz Pharmaceuticals Plc realized fall in Net Income from the third quarter by -35.87% to $ 94.15 millions, from $ 146.82 millions declared in the previous reporting period.

Within Major Pharmaceutical Preparations industry 13 other companies have achieved higher Net Income quarter on quarter growth. While Jazz Pharmaceuticals Plc's Net Income growth quarter on quarter, overall rank is 974.


Jazz Pharmaceuticals Plc's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Net Income 12 Months Ending $ 414.83 $ -20.68 $ -187.14 $ -256.92 $ -1,105.38
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
In the Dec 31 2023 period, Jazz Pharmaceuticals Plc had cumulative twelve months Net Income of $ 415 millions compare to net loss of $ -1,105 millions a year ago.

Jazz Pharmaceuticals Plc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment
In the Dec 31 2023 period, Jazz Pharmaceuticals Plc had cumulative twelve months Net Income of $ 415 millions compare to net loss of $ -1,105 millions a year ago.

Jazz Pharmaceuticals Plc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
JAZZ's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for JAZZ's Competitors
Net Income Growth for Jazz Pharmaceuticals Plc's Suppliers
Net Income Growth for JAZZ's Customers

You may also want to know
JAZZ's Annual Growth Rates JAZZ's Profitability Ratios JAZZ's Asset Turnover Ratio JAZZ's Dividend Growth
JAZZ's Roe JAZZ's Valuation Ratios JAZZ's Financial Strength Ratios JAZZ's Dividend Payout Ratio
JAZZ's Roa JAZZ's Inventory Turnover Ratio JAZZ's Growth Rates JAZZ's Dividend Comparisons



Companies with similar Net Income fall for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Net Income for the quarter ending Dec 31 2023
Charles River Laboratories International inc -0.08%$ -0.081 millions
Sanuwave Health Inc -0.23%$ -0.232 millions
Regeneron Pharmaceuticals Inc -3.13%$ -3.133 millions
Haemonetics Corporation-5.17%$ -5.169 millions
Resmed Inc -7.16%$ -7.165 millions
Edwards Lifesciences Corporation-7.20%$ -7.204 millions
Star Equity Holdings Inc -9.48%$ -9.481 millions
Bristol myers Squibb Company-12.99%$ -12.988 millions
Gilead Sciences Inc -13.23%$ -13.227 millions
Utah Medical Products Inc-13.50%$ -13.499 millions
Alpha Tau Medical Ltd -13.64%$ -13.640 millions
Masimo Corp-17.13%$ -17.125 millions
Merit Medical Systems Inc-17.28%$ -17.281 millions
Fresenius Medical Care Ag-18.10%$ -18.099 millions
Qiagen N v -19.35%$ -19.354 millions
Mettler toledo International Inc -30.49%$ -30.485 millions
Avantor Inc -30.49%$ -30.487 millions
Sanofi-35.93%$ -35.926 millions
Icu Medical Inc-38.15%$ -38.151 millions
Amedisys Inc -39.71%$ -39.707 millions
Avanos Medical Inc -40.34%$ -40.341 millions
Embecta Corp -42.90%$ -42.898 millions
Pro dex Inc -43.12%$ -43.117 millions
Becton Dickinson And Company-44.79%$ -44.794 millions
Bio techne Corp-45.08%$ -45.075 millions
Harmony Biosciences Holdings inc -45.15%$ -45.150 millions
Exagen Inc -45.72%$ -45.721 millions
Amgen Inc -52.54%$ -52.537 millions
Biogen Inc -54.70%$ -54.704 millions
Taro Pharmaceutical Industries Ltd-56.33%$ -56.330 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com